MedChemComm · 2014 · 43 citations · 101 references
Life SciencesBiochemistryMolecular BiologyPost-translational ModificationProtein TranslationCodon RecognitionPost-translational RegulationTranslation ControlTranslation RegulationTranslation TerminationTranslational RegulationPremature Termination CodonsPremature Translation TerminationStop Codon RecognitionStop Codon SuppressionTranslation Termination Regulation
models of a variety of different diseases models underling by PTC mutations. Although these derivatives hold great promise to serve as therapeutic candidates they also demonstrate the necessity to further understand the molecular mechanisms of which AGs confer their biological activity in eukaryotic cells for further rational drug design. Recent achievements in structural research shed light on AGs mechanism of action and opened a new avenue in the development of new and improved therapeutic derivatives. The following manuscript highlights these accomplishments and summarizes their contributions to the state of art rational drug design.
101
Recognition of Cognate Transfer RNA by the 30 <i>S</i> Ribosomal Subunit
J.M. Ogle, Ditlev E. Brodersen, William Clemons et al. · Science · 2001 · 1.2K citations
The Structure of the Eukaryotic Ribosome at 3.0 Å Resolution
Adam Ben‐Shem, Nicolas Garreau de Loubresse, Sergey Melnikov et al. · Science · 2011 · 1.1K citations
PTC124 targets genetic disorders caused by nonsense mutations
Ellen Welch, Elisabeth R. Barton, Jin Zhuo et al. · Nature · 2007 · 1.1K citations